Raymond James Upgrades Carvana to Market Perform

Raymond James analyst Mitch Ingles upgrades Carvana (NYSE:CVNA) from Underperform to Market Perform.

Raymond James analyst Mitch Ingles upgrades Carvana (NYSE:CVNA) from Underperform to Market Perform.

Total
0
Shares
Related Posts
Read More

eXp World Holdings Initiates Chief Financial Officer Transition Plan; Current CFO Jeff Whiteside To Remain At eXp World Holdings Through Dec. 1, 2023; Chief Accounting Officer Kent Cheng To Serve As Principal Financial Officer

Current CFO Jeff Whiteside to remain at eXp World Holdings through Dec. 1, 2023 Chief Accounting Officer Kent Cheng to Serve as Principal Financial OfficerBELLINGHAM, Wash., Nov. 09, 2023 (GLOBE NEWSWIRE) -- eXp

EXPI

Read More

Small-Cap Firm Century Therapeutics’ Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing

Century Therapeutics unveils plans to expand CNTY-101 clinical development into additional autoimmune diseases, including systemic lupus erythematosus. $60 million private placement supports R&D activities. Acquisition of Clade Therapeutics enhances pipeline with iPSC-focused programs.

IPSC